EWA
RCEL icon

EverSource Wealth Advisors’s Avita Medical RCEL Stock Holding History

EverSource Wealth Advisors’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.96K Buy
717
+433
+152% +$1.87K ﹤0.01% 3542
2026
Q1 		$1.05K Buy
+284
New +$1.19K ﹤0.01% 3845
2025
Q4 		– Sell
-76
Closed -$388 – 4411
2025
Q3 		$388 Buy
76
+49
+181% +$256 ﹤0.01% 4012
2025
Q2 		$143 Sell
27
-129
-83% -$938 ﹤0.01% 4087
2025
Q1 		$1.27K Buy
+156
New +$1.46K ﹤0.01% 3142

Other funds holding RCEL

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

EverSource Wealth Advisors's RCEL Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Avita Medical (RCEL) stake by 152% in Q2 2026, buying an estimated $1.87K and bringing the position to 717 shares worth $2.96K. The position accounts for ﹤0.01% of the portfolio, ranked #3542.

EverSource Wealth Advisors first reported a position in RCEL in Q1 2025 and has held it in 5 quarters since. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • EverSource Wealth Advisors held 717 shares of Avita Medical worth $2.96K as of Q2 2026.
  • EverSource Wealth Advisors bought 433 Avita Medical shares in Q2 2026, an estimated $1.87K.
  • Avita Medical made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3542 holding.
  • EverSource Wealth Advisors first reported a position in Avita Medical in Q1 2025 and has held it in 5 quarters since.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.